Guidelines for patient management: considerations before adoption into practice
- PMID: 35067683
- PMCID: PMC9151777
- DOI: 10.1038/s41433-021-01898-z
Guidelines for patient management: considerations before adoption into practice
Conflict of interest statement
AJD: Nothing to disclose. JWB: Nothing to disclose. MRP: Nothing to disclose. RPS: Consultant: Novartis, Genentech/Roche, Alcon, Regeneron, Bayer, Optos, Genentech, Apellis – unrelated to this study. FGH: Research funds: Acucela, Allergan, Apellis, Bayer, Bioeq/Formycon, Roche/Genentech, Geuder, Heidelberg Engineering, IvericBio, Kanghong, Novartis, NightStarX, Zeiss; Personal fees: Boehringer-Ingelheim, Grayburg Vision, LinBioscience, Pixium Vision, Stealth BioTherapeutics, Aerie, Oxurion – unrelated to this study. LT: Nothing to disclose. MB: Research funds: Pendopharm, Bioventus, Acumed – unrelated to this study. VC: Advisory Board Member: Alcon, Roche, Bayer, Novartis; Grants: Bayer, Novartis – unrelated to this study.
Comment on
-
A decision aid to facilitate informed choices among cataract patients: A randomized controlled trial.Patient Educ Couns. 2021 Jun;104(6):1295-1303. doi: 10.1016/j.pec.2020.10.036. Epub 2020 Nov 9. Patient Educ Couns. 2021. PMID: 33191060 Clinical Trial.
References
-
- Steinberg E, Greenfield S, Wolman DM, Mancher M, Graham R, editors. Clinical practice guidelines we can trust. National Academies Press; National Academy of Sciences.; 2011 Jul. - PubMed
Publication types
LinkOut - more resources
Full Text Sources